Avid Bioservices Inc (CDMO)

[nuke661]

ex,

I posted months ago IR's response to my query for clarification on the disconnect remark. Here again is that exchange. Anyone obviously can choose to believe it or not. However, its easy enough for anyone here to send their own email to Chris Keenan (the address is in the exchange below)to confirm. Note: I have removed my identifying information, other than that you have the whole exchange below.
It starts with the body of Chris Keenan's reply to my question lower in the thread

"Timing of readout from the trials. As these are two different diseases, patients within these groups live different durations following diagnosis.


Chris Keenan | Senior Director, Investor Relations

Peregrine Pharmaceuticals, Inc.
14282 Franklin Avenue - Tustin, CA - 92780
Tel: [phone] | Corporate: | Fax:
[e-mail] | www.peregrineinc.com

_______________________________________
Sent: Monday, February 11, 2013 6:55 AM
To: Chris Keenan
Subject: Request for Clarification on Statement Made by Steve King

Good Day Mr. Keenan.

I am a stockholder of Peregrine Pharmaceuticals and have been since about 2005. If you have the time I would appreciate some clarification regarding a statement made by Mr. King during the 12-10-12 conference call.

According to the transcript of the 12-10-12 conference call Mr. King made the following statement:

“All along, of course, the Front-Line data & Pancreatic data have been sort of looming out there and obviously, over time, will mature. As far as the trigger points for those data points, these are event-driven endpoints, and it's good for patients the longer they go out. Having said that, when we do reach what we think is a good solid result from the studies, and we will be in a position to put those out as they become available, and, obviously, there will likely be a disconnect between those 2 particular clinical results.”

I would greatly appreciate it if you could provide me with exactly what type of “disconnect” Mr. King was referring to. I believe this information to be very important to evaluating the information being provided to shareholders.

Thank you for your time,"

Therefore, the disconnect has no hidden negative meaning that constantly seems to find life here on this board. Also, if anyone goes back to the "moving the needle" thread and reads all the exchanges during the 1st 24 hours after that comment was made anyone will find that comment is without foundation as it constantly keeps being presented on this board. It was someone's interpretation of IR statements, not any actual IR statement.